Table 1.
Statistically significant differences in lipoprotein particles and metabolites between blood serum samples obtained from patients suffering from LP and HC.
| Composition of Lipoprotein Particles and Metabolites | Mean for LP | Mean for HC | Wilcox-Test LP vs. HC, p < 0.0029 |
|---|---|---|---|
| Large LDL | |||
| L-LDL-L | 0.4 | −0.39 | 0.0007 |
| L-LDL-C | 0.41 | −0.4 | 0.0008 |
| L-LDL-FC | 0.41 | −0.39 | 0.0008 |
| L-LDL-CE | 0.4 | −0.39 | 0.001 |
| L-LDL-PL | 0.4 | −0.38 | 0.0011 |
| LDL | |||
| LDL-FC | 0.39 | −0.38 | 0.0008 |
| LDL-C | 0.38 | −0.37 | 0.0024 |
| LDL-L | 0.38 | −0.37 | 0.0027 |
| IDL | |||
| IDL-PL | 0.4 | −0.39 | 0.0013 |
| IDL-CE | 0.4 | −0.39 | 0.0021 |
| IDL-C | 0.4 | −0.39 | 0.0023 |
| IDL-FC | 0.39 | −0.38 | 0.0027 |
| Clinical LDL cholesterol and its values | |||
| Clinical LDL-C * | 0.39 | −0.38 | 0.0014 |
| Total C | 0.41 | −0.4 | 0.0016 |
| Cholesteryl esters | |||
| Total CE | 0.41 | −0.39 | 0.0013 |
| Free cholesterol | |||
| Total FC | 0.4 | −0.39 | 0.0028 |
C–cholesterol; CE–cholesteryl esters; FC–free cholesterol; HC–healthy controls; IDL–intermediate-density lipoprotein; L-–large; -L–total lipids; LDL–low-density lipoprotein; LP–lichen planus; PL–phospholipids. * Clinical LDL-C can be obtained from the NMR-based measures with the equation clinical LDL-C = LDL-C + IDL-C + XS-VLDL × 0.15.